Your browser doesn't support javascript.
loading
The effectiveness of interventions to treat hypothalamic obesity in survivors of childhood brain tumours: a systematic review.
Wang, K-W; Chau, R; Fleming, A; Banfield, L; Singh, S K; Johnston, D L; Zelcer, S M; Rassekh, S R; Burrow, S; Valencia, M; de Souza, R J; Thabane, L; Samaan, M C.
Affiliation
  • Wang KW; Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
  • Chau R; Division of Pediatric Endocrinology, McMaster Children's Hospital, Hamilton, Ontario, Canada.
  • Fleming A; Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
  • Banfield L; Division of Pediatric Endocrinology, McMaster Children's Hospital, Hamilton, Ontario, Canada.
  • Singh SK; Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
  • Johnston DL; Division of Pediatric Hematology/Oncology, McMaster Children's Hospital, Hamilton, Ontario, Canada.
  • Zelcer SM; Health Sciences Library, McMaster University, Hamilton, Ontario, Canada.
  • Rassekh SR; Division of Neurosurgery, Department of Surgery, McMaster Children's Hospital, Hamilton, Ontario, Canada.
  • Burrow S; McMaster Stem Cell and Cancer Research Institute, McMaster University, Hamilton, Ontario, Canada.
  • Valencia M; Division of Pediatric Hematology/Oncology, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
  • de Souza RJ; Pediatric Hematology Oncology, Children's Hospital, London Health Sciences Center, London, Ontario, Canada.
  • Thabane L; Division of Pediatric Hematology/ Oncology/BMT, Department of Pediatrics, British Columbia Children's Hospital, Vancouver, British Columbia, Canada.
  • Samaan MC; Division of Orthopedic Surgery, Department of Surgery, McMaster University Medical Centre, Hamilton, Ontario, Canada.
Obes Rev ; 18(8): 899-914, 2017 08.
Article in En | MEDLINE | ID: mdl-28544764
ABSTRACT

BACKGROUND:

Survivors of childhood brain tumours (SCBT) are at risk of type 2 diabetes and cardiovascular diseases. Obesity is a major driver of cardiometabolic diseases in the general population, and interventions that tackle obesity may lower the risk of these chronic diseases. The goal of this systematic review was to summarize current evidence for the presence of interventions to manage obesity, including hypothalamic obesity, in SCBT.

METHODS:

The primary outcome of this review was the body mass index z-score change from baseline to the end of the intervention and/or follow-up. Literature searches were conducted in PsycINFO, CINAHL, the Cochrane Library, Medline, SPORTDiscus, EMBASE and PubMed. Two reviewers completed study evaluations independently.

RESULTS:

Eleven publications were included in this systematic review (lifestyle intervention n = 2, pharmacotherapy n = 6 and bariatric surgery n = 3). While some studies demonstrated effectiveness of interventions to manage obesity in SCBT and alter markers of obesity and cardiometabolic risk, the evidence base was limited and of low quality, and studies focused on hypothalamic obesity. We conclude that there is urgent need to conduct adequately powered trials of sufficient duration, using existing and novel therapies to manage obesity, reduce the burden of cardiometabolic disorders and improve outcomes in SCBT.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Anti-Obesity Agents / Bariatric Surgery / Hypothalamic Diseases / Life Style / Obesity Type of study: Etiology_studies / Systematic_reviews Limits: Humans Language: En Journal: Obes Rev Journal subject: METABOLISMO Year: 2017 Document type: Article Affiliation country: Canadá

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Anti-Obesity Agents / Bariatric Surgery / Hypothalamic Diseases / Life Style / Obesity Type of study: Etiology_studies / Systematic_reviews Limits: Humans Language: En Journal: Obes Rev Journal subject: METABOLISMO Year: 2017 Document type: Article Affiliation country: Canadá
...